Updated:
tb innovations
TB Innovations is a Tokyo venture capital firm investing in healthcare, AI and robotics companies based in Japan.
tb innovations
TB Innovations was founded in 2020. The firm operates as a venture capital manager with no publicly named principals or wealth-origin details. The firm targets seed, start-up and expansion rounds. It deploys capital into healthcare, life sciences, artificial intelligence and robotics. All documented activity remains inside Japan. No co-investors or specific portfolio companies appear in available records. Team size and office locations beyond Tokyo remain undisclosed. No adjacent vehicles or dated operational events from the last 24 months are recorded. The firm maintains a narrow geographic and sector mandate with no disclosed fund vehicles or external LP relationships.
General information
Firm type
Private Equity
Year founded
2020
AUM
37 (Altss estimate)
Location
Region
Asia
Country
Japan
City
Tokyo
Corporate office
Tokyo, Japan
Sector focus
Frequently asked questions
Who runs investment decisions at tb innovations?
No principals are named in public sources.
Does tb innovations participate in fund commitments or only direct deals?
Available records show only direct venture investments.
What investment stages does tb innovations typically target?
The firm covers seed through growth rounds.
Where does tb innovations invest geographically?
The firm invests exclusively in Japan-based companies.
Which sectors does tb innovations focus on?
Focus areas include healthcare, life sciences, artificial intelligence and robotics.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: